Marinus Pharmaceuticals (MRNS) PT Raised to $3 at Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Marinus Pharmaceuticals (MRNS) PT Raised to $3 at Jefferies

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2016 Financial Results

August 9, 2016 4:16 PM EDT

RADNOR, Pa., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today provided a business update and announced its financial results for the second quarter ended June 30, 2016.

Marinus is committed to developing ganaxolone, a CNS-selective GABAA modulator, for children and adults suffering from status... More